$397 Million is the total value of 5AM Venture Management, LLC's 12 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 27.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VOR | VOR BIOPHARMA INC | $124,814,000 | -56.7% | 6,692,429 | 0.0% | 31.41% | -39.5% | |
| AKUS | AKOUOS INC | $51,904,000 | -9.5% | 4,135,784 | 0.0% | 13.06% | +26.5% | |
| IDYA | IDEAYA BIOSCIENCES INC | $37,741,000 | -10.7% | 1,798,066 | 0.0% | 9.50% | +24.8% | |
| FIXX | HOMOLOGY MEDICINES INC | $32,976,000 | -22.7% | 4,535,919 | 0.0% | 8.30% | +8.0% | |
| ARVN | Sell | ARVINAS INC | $30,800,000 | -6.8% | 400,000 | -20.0% | 7.75% | +30.2% |
| CRNX | CRINETICS PHARMACEUTICALS IN | $25,679,000 | +23.4% | 1,362,286 | 0.0% | 6.46% | +72.4% | |
| CABA | CABALETTA BIO INC | $25,665,000 | -22.5% | 2,984,263 | 0.0% | 6.46% | +8.3% | |
| IMPL | New | IMPEL NEUROPHARMA INC | $25,530,000 | – | 2,884,791 | +100.0% | 6.42% | – |
| SCPH | SCPHARMACEUTICALS INC | $23,410,000 | -8.1% | 3,831,474 | 0.0% | 5.89% | +28.4% | |
| JANX | New | JANUX THERAPEUTICS INC | $11,134,000 | – | 446,266 | +100.0% | 2.80% | – |
| CDTX | CIDARA THERAPEUTICS INC | $4,053,000 | -24.1% | 2,006,511 | 0.0% | 1.02% | +6.1% | |
| FVAM | 5 01 ACQUISITION CORP | $3,640,000 | -0.2% | 365,126 | 0.0% | 0.92% | +39.4% | |
| APRE | Exit | APREA THERAPEUTICS INC | $0 | – | -619,157 | -100.0% | -0.57% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HOMOLOGY MEDICINES INC | 16 | Q3 2023 | 26.6% |
| ARVINAS INC | 16 | Q3 2023 | 14.3% |
| Crinetics Pharmaceuticals, Inc. | 16 | Q3 2023 | 12.8% |
| SCPHARMACEUTICALS INC | 16 | Q3 2023 | 7.5% |
| CIDARA THERAPEUTICS INC | 16 | Q3 2023 | 1.7% |
| IDEAYA BIOSCIENCES INC | 14 | Q1 2023 | 11.4% |
| VOR BIOPHARMA INC | 11 | Q3 2023 | 51.9% |
| CABALETTA BIO INC | 11 | Q2 2022 | 14.2% |
| AKOUOS INC | 10 | Q3 2022 | 27.7% |
| IMPEL PHARMACEUTICALS INC | 10 | Q3 2023 | 7.1% |
View 5AM Venture Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-03 |
| 13F-HR | 2021-11-15 |
View 5AM Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.